FL118 Is a Potent Therapeutic Agent against Chronic Myeloid Leukemia Resistant to BCR-ABL Inhibitors through Targeting RNA Helicase DDX5.

FL118 - Canget

http://www.ncbi.nlm.nih.gov/pubmed/38612503

Erika Kobayashi; Kengo Takeda; Kenji Tago; Megumi Funakoshi-Tago; Miu Nagao; Satoshi Ohta

Apr 13, 2024